Akebia Therapeutics Stock News & Updates
[WKN: A1XF0S | Symbol: AKBA]
Akebia Therapeutics
Analysts' Top 5 Price Targets of June 4, 2025
Analysts' Top 5 Price Targets of April 1, 2025
PNE AG [DE000A0JBPG2]: Warburg Research confirms Buy rating with a price target of €23.80 (66% upside...
Akebia Therapeutics (AKBA): BTIG Sees 316% Price Potential - Potential in the CKD Market is Significantly Underestimated According to Experts!
Akebia Therapeutics Inc. (AKBA) is a biopharmaceutical company focused on the development and commercialization...
TOP-5 Price Targets by Analysts on January 24, 2025
Super Group [GG00BMG42V42]: Canaccord upgrades from "Hold" to "Buy" and doubles price target from 5 to...
- ‹
- 1
- ›